Michele Tana, MD, MHS

Associate Clinical Professor

Michele Tana grew up in Northern Virginia, studied the Classics at Harvard College, and attended Harvard Medical School. She trained in Internal Medicine at Stanford University Hospital and Clinics and Gastroenterology at California Pacific Medical Center. She was a Hepatology Fellow at the National Institutes of Health in the National Institute of Diabetes and Digestive and Kidney Diseases and earned a Masters Degree in Clinical Research from Duke University.
Dr. Tana joined the UCSF faculty in 2013. She serves the vulnerable patient population at Zuckerberg San Francisco General Hospital and teaches UCSF students and trainees. She directs the Gastroenterology Rotation for Surgery Residents and serves as a Hepatitis C Consultant for the National Clinician Consultation Center. In 2018, she helped launch Prospective Observational Study to Understand Liver Diseases (POSULD). Her team collaborates with researchers across disciplines and across the globe to apply state-of-the-art science and technology to liver diseases, with a focus on health equity in autoimmune hepatitis.

Education
2020 - Diversity, Equity, and Inclusion Champion Training, University of California
M.H.S., 2016 - Clinical Research, Duke University
Hepatology, 2013 - NIDDK, National Institutes of Health
Gastroenterology, 2011 - Department of Medicine, California Pacific Medical Center
Internal Medicine, 2008 - School of Medicine, Stanford University
M.D., 2005 - Medical Schoool, Harvard University
A.B., 2000 - Classics, Harvard College
Websites
Publications

  1. Hundt M, Chen A, Donovan J, Kim N, Yilma M, Tana M, Mehta N, Zhou K. Barriers to liver transplant referral in safety net settings: A national provider survey. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2024. PMID: 38687168


  2. Feuille C, Kari S, Patel R, Oberoi R, Liu J, Ohliger M, Khalili M, Tana M. Utility and impact of magnetic resonance elastography in the clinical course and management of chronic liver disease. Scientific Reports 2024. PMID: 38242967


  3. Patel S, Kim RG, Shui AM, Magee C, Lu M, Chen J, Tana M, Huang CY, Khalili M. Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those With Unhealthy Alcohol Use. Gastro Hep Advances 2023. PMID: 39100862


  4. Bositis CM, Tana MM. Timely Treatment Translates: A Vision for Eradicating HCV. NAM Perspectives 2023. PMID: 37916069


  5. Klepper A, Kung A, Vazquez SE, Mitchell A, Mann S, Zorn K, Avila-Vargas I, Kari S, Tekeste M, Castro J, Lee B, Duarte M, Khalili M, Yang M, Wolters P, Price J, Perito E, Feng S, Maher JJ, Lai J, Weiler-Normann C, Lohse AW, DeRisi J, Tana M. Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights. medRxiv : the preprint server for health sciences 2023. PMID: 37398174


  6. Yilma M, Kim NJ, Shui AM, Tana M, Landis C, Chen A, Bangaru S, Mehta N, Zhou K. Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals. JAMA network open 2023. PMID: 37289453


  7. Hercun J, Noureddin M, Noureddin N, Eccleston J, Woolridge D, Liang TJ, Tana M, Kleiner DE, Rodriguez GV, Koh C, Hoofnagle JH, Heller T. Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis. The American journal of gastroenterology 2022. PMID: 36066458


  8. Tana MM, Klepper A, Lyden A, Pisco AO, Phelps M, McGee B, Green K, Feng S, DeRisi J, Crawford ED, Lammert CS. Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management. 2022. PMID: 35312680


  9. Wang CW, Grab J, Tana MM, Irani RA, Sarkar M. Outcomes of Pregnancy in Autoimmune Hepatitis: A Population-Based Study. Hepatology (Baltimore, Md.) 2021. PMID: 34455632


  10. Sangaramoorthy M, Yang J, Guan A, DeRouen MC, Tana MM, Somsouk M, Thompson CA, Gibbons J, Ho C, Chu JN, Cheng I, Gomez SL, Shariff-Marco S. Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update. 2021. PMID: 34853019


  11. Deng LX, Tana MM, Lai JC. Thinking Ahead: Advance Care Planning for Patients With Cirrhosis. 2021. PMID: 35106142


  12. Lee BT, Tana MM, Kahn JA, Dara L. We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases. Hepatology (Baltimore, Md.) 2021. PMID: 34056734


  13. Gara N, Tana MM, Kattapuram M, Auh S, Sullivan L, Fryzek N, Walter M, Umarova R, Zhao X, Cloherty G, Doo E, Heller T, Liang TJ, Ghany MG. Prospective Study of Withdrawal of Antiviral therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response. Hepatology communications 2021. PMID: 34558806


  14. Tana MM, McCoy D, Lee B, Patel R, Lin J, Ohliger MA. Texture features from computed tomography correlate with markers of severity in acute alcohol-associated hepatitis. Scientific Reports 2020. PMID: 33087739


  15. Huynh MP, Bradshaw PT, Tana MM, Rachocki C, Somsouk M. Obesity and metabolic outcomes in a safety-net health system. Biodemography and social biology 2020. PMID: 32727275


  16. Sangaramoorthy M, Yang J, DeRouen MC, Ho C, Somsouk M, Tana MM, Thompson CA, Gibbons J, Gomez SL, Shariff-Marco S. Disparities in Hepatocellular Carcinoma Incidence in California: An Update. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019. PMID: 31719066


  17. Galoosian A, Hanlon C, Tana M, Cheung R, Wong RJ. Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample. Digestive diseases and sciences 2019. PMID: 31489564


  18. Kapuria D, Ben-Yakov G, Ortolano R, Cho MH, Kalchiem-Dekel O, Takyar V, Lingala S, Gara N, Tana M, Kim YJ, Kleiner DE, Young NS, Townsley DM, Koh C, Heller T. The Spectrum of Hepatic Involvement in Patients With Telomere Disease. Hepatology (Baltimore, Md.) 2019. PMID: 30791107


  19. Lee B, Holt EW, Wong RJ, Sewell JL, Somsouk M, Khalili M, Maher JJ, Tana MM. Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved. Autoimmunity 2018. PMID: 29890851


  20. Wen JW, Kohn MA, Wong R, Somsouk M, Khalili M, Maher J, Tana MM. Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans. Volume 113 of Issue 2. The American journal of gastroenterology 2018. PMID: 29380822


  21. Baghdanian AH, Baghdanian AA, Puppala S, Tana M, Ohliger MA. Imaging Manifestations of Peptic Ulcer Disease on Computed Tomography. Seminars in ultrasound, CT, and MR 2017. PMID: 29571554


  22. Tana MM, Alao H, Morris N, Bernstein S, Hattenbach J, Brychta R, Sarkar S, Zhao X, Walter M, Buckley A, Chen K, Rotman Y. Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms Fatigue: Biomedicine, Health & Behavior. 2017. PMID:


  23. Tana MM, Alao H, Morris N, Bernstein S, Hattenbach J, Rehman RB, Brychta R, Sarkar S, Zhao X, Walter M, Buckley A, Chen K, Rotman Y. Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms. Fatigue : biomedicine, health & behavior 2017. PMID: 30546968


  24. Tana MM, Muir AJ. Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue? Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017. PMID: 28694131


  25. van Wijk XMR, Magee CA, Wu AHB, Tana MM, Lynch KL. A comparison of methods for evaluation of a case of suspected macro-aspartate aminotransferase. Clinica chimica acta; international journal of clinical chemistry 2016. PMID: 27732874


  26. Ha J, Yan M, Aguilar M, Bhuket T, Tana MM, Liu B, Gish RG, Wong RJ. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. Cancer 2016. PMID: 27195481


  27. Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies. Journal of clinical gastroenterology 2016. PMID: 26583267


  28. Tana MM, Shums Z, Milo J, Norman GL, Leung PS, Gershwin ME, Noureddin M, Kleiner DE, Zhao X, Heller T, Hoofnagle JH. The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis. American journal of clinical pathology 2015. PMID: 26386081


  29. Tana MM, Zhao X, Bradshaw A, Moon MS, Page S, Turner T, Rivera E, Kleiner DE, Heller T. Factors associated with the platelet count in patients with chronic hepatitis C. Thrombosis research 2015. PMID: 25728497


  30. Tana MM, Heller T. Autoantibodies in hepatitis C: red flag or bystander effect? Journal of pediatric gastroenterology and nutrition 2013. PMID: 23443062


  31. Tana MM, Ghany MG. Hepatitis B virus treatment: Management of antiviral drug resistance. Clinical liver disease 2013. PMID: 30992816


  32. Tana MM, Hoofnagle JH. Scar undone: long-term therapy of hepatitis B. Lancet (London, England) 2012. PMID: 23234726